Dermatologic DiseasesNCT03913598
Internet and Social Media Use in Dermatology Patients
An observational study of Dermatologic Diseases, run by University Hospital, Basel, Switzerland at 1 site in Switzerland.
Trial summary
This study is to assess Internet and social media use in dermatology patients Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Dermatologic Diseases
- What is being tested?
- patient questionnaire
- How many people
- 650 participants
- Where
- 1 siteSwitzerland
- Study dates
- 21 Mar 2019to 20 Apr 2019
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Outpatients treated at the Department of Dermatology of University Hospital Basel
Who may be able to join
- Patients treated at the Department of Dermatology of University Hospital Basel
Who cannot join
- Insufficient knowledge of German language
Trial locations and contacts
1 site in 1 country.
Switzerland1 site
Department of Dermatology, University Hospital Basel
Basel, 4031
About this study
Official title: Internet and Social Media Use in Dermatology Patients - a Survey
This study is to assess Internet and social media use in dermatology patients
Read the detailed description
The Internet and social media bear potential in terms of heath care consumer education, prevention of diseases and dissemination of evidence-based information. The use of the internet and social media platforms both by dermatologists and patients is rapidly evolving. In order to improve the presence and visibility of dermatology-related evidence-based informations on the Internet and in social media, the use and behavior of dermatology patients in this context is studied in more detail.
- Conditions
- Dermatologic Diseases
- Being tested
- patient questionnaire
- Keywords
- social media use, online medical services, internet use
- Medical subject headings
- Skin Diseases
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
patient questionnaireOther
self-administered patient questionnaire regarding the different aspects of internet and social media use in dermatology patients
What is being measured
The primary outcome is the main question the study is designed to answer.
Use of the Internet as a source of medical information
self-administered patient questionnaire regarding motivation to seek for medical information on the Internet
Measured: single time point assessment at baseline
Use of Social media as a source of medical information
self-administered patient questionnaire regarding motivation to seek for medical information in Social media
Measured: single time point assessment at baseline
Duration of Internet/ Social media use by dermatology patients
self-administered patient questionnaire covering duration of Internet/ Social media use (up to 2 hours/ day; 2 to 4 hours/day; more than 4 hours/day)
Measured: single time point assessment at baseline
Quality assessment (by patients) of medical information provided
self-administered patient questionnaire covering quality of medical information provided on the Internet (5 point self-rating scale from very bad to very good)
Measured: single time point assessment at baseline
Impact of internet/social media on the patient-physician relationship
self-administered patient questionnaire covering impact of internet/social media on the patient-physician relationship (self-rating scale: positive/ negative/ no impact)
Measured: single time point assessment at baseline
Previous use of online medical services and online shopping of drugs/medications
self-administered patient questionnaire assessing previous use of online medical services and online shopping of drugs/medications (yes/ no)
Measured: single time point assessment at baseline
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted12 Apr 2019
- Study start21 Mar 2019
- Primary completion20 Apr 2019
- Study completion20 Apr 2019
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Dermatologic DiseasesStudies of the same condition, open and under way.
- More trials run by University Hospital, Basel, SwitzerlandThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Cross-sectional
- Enrolment
- 650 participants (actual)
Sponsor and investigators
- Lead sponsor
- University Hospital, Basel, Switzerland
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Simon Müller, Dr. med, Principal investigator, Department of Dermatology, University Hospital Basel
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03913598
- Sponsor's protocol ID
- 2019-00009; sp19Mueller3
- Other IDs
- 2019
- Status last verified
- Sep 2019
- First submitted
- 10 Apr 2019
- Last updated
- 18 Sep 2019
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 18 Sep 2019. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Internet and Social Media Use in Dermatology Patients - a Survey
- ClinicalTrials.gov ID
- NCT03913598
- Acronym / sponsor ID
- 2019-00009; sp19Mueller3
- Conditions
- Dermatologic Diseases
- Keywords
- social media use, online medical services, internet use
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 650 participants (actual)
- Lead sponsor
- University Hospital, Basel, SwitzerlandUniversity, hospital or other
- Study start
- 21 Mar 2019 (actual)
- Primary completion
- 20 Apr 2019 (actual)
- Study completion
- 20 Apr 2019 (actual)
- First posted
- 12 Apr 2019 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study is to assess Internet and social media use in dermatology patients
Detailed description
The Internet and social media bear potential in terms of heath care consumer education, prevention of diseases and dissemination of evidence-based information. The use of the internet and social media platforms both by dermatologists and patients is rapidly evolving. In order to improve the presence and visibility of dermatology-related evidence-based informations on the Internet and in social media, the use and behavior of dermatology patients in this context is studied in more detail.
Study design
- Observational model
- Cohort
- Time perspective
- Cross-sectional
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Outpatients treated at the Department of Dermatology of University Hospital Basel
Key inclusion criteria (1 listed)
- Patients treated at the Department of Dermatology of University Hospital Basel
Key exclusion criteria (1 listed)
- Insufficient knowledge of German language
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| patient questionnaireself-administered patient questionnaire regarding the different aspects of internet and social media use in dermatology patients | Other | – |
Primary outcome
Use of the Internet as a source of medical information
Time frame: single time point assessment at baseline
self-administered patient questionnaire regarding motivation to seek for medical information on the Internet
Use of Social media as a source of medical information
Time frame: single time point assessment at baseline
self-administered patient questionnaire regarding motivation to seek for medical information in Social media
Duration of Internet/ Social media use by dermatology patients
Time frame: single time point assessment at baseline
self-administered patient questionnaire covering duration of Internet/ Social media use (up to 2 hours/ day; 2 to 4 hours/day; more than 4 hours/day)
Quality assessment (by patients) of medical information provided
Time frame: single time point assessment at baseline
self-administered patient questionnaire covering quality of medical information provided on the Internet (5 point self-rating scale from very bad to very good)
Impact of internet/social media on the patient-physician relationship
Time frame: single time point assessment at baseline
self-administered patient questionnaire covering impact of internet/social media on the patient-physician relationship (self-rating scale: positive/ negative/ no impact)
Previous use of online medical services and online shopping of drugs/medications
Time frame: single time point assessment at baseline
self-administered patient questionnaire assessing previous use of online medical services and online shopping of drugs/medications (yes/ no)
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 18 Sep 2019.
Related trials for Dermatologic Diseases
Not yet recruitingPhase 2
Extension Study of Safety and Tolerability of DDY391 in Participants With Moderate to Severe Psoriatic Arthritis (CDDY391A12201-extension)
Moderate to Severe Psoriatic Arthritis
RecruitingPhase 1/2
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
Solid Tumor, Non-Small Cell Lung Cancer
RecruitingPhase 1
IL-17 Blockade to Decrease irAEs (REPLAY)
Metastatic Melanoma
Active, not recruiting
Streamlined Geriatric and Oncological Evaluation Based On IC Technology
Breast Cancer, Comorbidities and Coexisting Conditions
RecruitingPhase 2
Gene Signatures to Guide HR+MBC Therapy in a Diverse Cohort
Invasive Mammary Carcinoma, Metastatic Breast Cancer
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Simon Müller, Dr. med principal investigator
Department of Dermatology, University Hospital Basel
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Dermatologic Diseases, run by University Hospital, Basel, Switzerland at 1 site in Switzerland.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 18 Sep 2019. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Switzerland. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Use of the Internet as a source of medical information (time frame: single time point assessment at baseline). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Sep 2019.